These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1822408)

  • 1. Naftifine: a topical allylamine antifungal agent.
    Mühlbacher JM
    Clin Dermatol; 1991; 9(4):479-85. PubMed ID: 1822408
    [No Abstract]   [Full Text] [Related]  

  • 2. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP; Brogden RN
    Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naftifine: a review.
    Gupta AK; Ryder JE; Cooper EA
    J Cutan Med Surg; 2008; 12(2):51-8. PubMed ID: 18346400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contact allergy to the antifungal agent naftifin].
    Hoting E; Küchmeister B; Hausen BM
    Derm Beruf Umwelt; 1987; 35(4):124-7. PubMed ID: 2959458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftifine treatment of resistant dermatophytosis.
    Rosen T; Fischer M; Orengo I; Abuabara F
    Int J Dermatol; 1991 Aug; 30(8):590-2. PubMed ID: 1938060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naftifine treatment for dermatophytosis: multicenter clinical investigations in Turkey. Turkish Multicenter Dermatophytosis Study Group.
    Int J Dermatol; 1992 Apr; 31(4):247-8. PubMed ID: 1503576
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
    Nada M; Hanafi S; al-Omari H; Mokhtar M; el-Shamy S; Mühlbacher J
    Int J Dermatol; 1994 Aug; 33(8):570-2. PubMed ID: 7960355
    [No Abstract]   [Full Text] [Related]  

  • 10. Allylamine antifungal drugs.
    Ryder NS; Mieth H
    Curr Top Med Mycol; 1992; 4():158-88. PubMed ID: 1732066
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal agents: an overview. Part II.
    Gupta AK; Sauder DN; Shear NH
    J Am Acad Dermatol; 1994 Jun; 30(6):911-33; quiz 934-6. PubMed ID: 7619094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naftifine for fungal skin infections.
    Med Lett Drugs Ther; 1988 Oct; 30(777):98-9. PubMed ID: 3050410
    [No Abstract]   [Full Text] [Related]  

  • 13. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin.
    Evans EG; James IG; Seaman RA; Richardson MD
    Br J Dermatol; 1993 Oct; 129(4):437-42. PubMed ID: 8217759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%.
    Plaum S; Verma A; Fleischer AB; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Sep; 12(9):1004-8. PubMed ID: 24002147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of SN 105-843 gel in vivo.
    Haroon TS; Qazi AA; Khan KA; Farooqi AH
    J Pak Med Assoc; 1981 Jun; 31(6):123-6. PubMed ID: 6792389
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses.
    Leiste D; Braun W; Fegeler W; Fegeler K; Stary A; Ruping KW; Klaschka F; Colli E; Sartani A
    Curr Med Res Opin; 1989; 11(9):567-75. PubMed ID: 2692971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problem of external therapy used in skin mycosis].
    Tarasenko GN; Patronov IV; Kuz'mina IuV; Tarasenko IuG
    Voen Med Zh; 2004 Aug; 325(8):38-9. PubMed ID: 15471414
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of naftifine (Exoderil) cream in the treatment of dermatophytosis.
    Lee CT; Giam YC; Tan T
    Singapore Med J; 1987 Oct; 28(5):429-31. PubMed ID: 3324355
    [No Abstract]   [Full Text] [Related]  

  • 20. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.